The AMINOPHYLLINE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, primary_container_type: AMPUL, therapeutic_equivalent: ABBOTT LABS. HOSP.
PRODS. DIV., secondary_container_type: BOX, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 50. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System under NSN 6505-01-220-1277, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| primary_container_type | AMPUL |
| therapeutic_equivalent | ABBOTT LABS. HOSP. PRODS. DIV. |
| secondary_container_type | BOX |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 50 |
| primary_container_content_quantity | 20.000 MILLILITERS |
| total_secondary_container_quantity | 2 |
| active_medicament_medicinal_strength | 25.000 MILLIGRAMS THEOPHYLLINE PER MILLILITER |
| primary_container_quantity_per_secondary_container | 25 AMPUL |
| NSN | 6505-01-220-1277 |
| TOTAL PRIMARY CONTAINER QUANTITY | 50 |
| PRIMARY CONTAINER TYPE | AMPUL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS THEOPHYLLINE PER MILLILITER |
| THERAPEUTIC EQUIVALENT | ABBOTT LABS. HOSP. PRODS. DIV. |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER CONTENT QUANTITY | 20.000 MILLILITERS |
| PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 25 AMPUL |
| SECONDARY CONTAINER TYPE | BOX |
| ADMINISTRATION | INTRAVENOUS |
| TOTAL SECONDARY CONTAINER QUANTITY | 2 |